Published
Ultra-Violet Spectrophotometric Method for Validation of Rupatadine Fumarate from Bulk Drug and Pharmaceutical Formulation
Published in June 2014 Issue 3 (Vol. 4, Issue 3, 2014)

Abstract
A simple, rapid, sensitive and precise UV spectrophotometric method has been developed for the estimation of rupatadine fumarate from bulk drug and pharmaceutical formulation. In this method rupatadine fumarate showed maximum absorbance at about 250 nm in absolute alcohol. Beer’s law was followed in the concentration range of 1 to 30 μg/ ml. Regression equation was found to be y = 0.0257- 3x 10-5 and coefficient of correlation was 0.9999 . The proposed method is accurate, sensitive, reproducible and useful for the estimation of rupatadine fumarate from bulk drug and pharmaceutical formulation.
Authors (2)
Rele Rajan V
View all publications →Tiwatane Prathamesh P
View all publications →Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Summarise this paper with AI:
Article Information
Published in:
June 2014 Issue 3 (Vol. 4, Issue 3, 2014)Article Impact
Views:1,789
Downloads:680
How to Cite
Rajan, R., & Prathamesh, T. (2014). Ultra-Violet Spectrophotometric Method for Validation of Rupatadine Fumarate from Bulk Drug and Pharmaceutical Formulation. American Journal of PharmTech Research, 4(3), xx-xx. https://ajptr.com/articles/AJPTR43062
Article Actions
More from this Issue
An Abrust- for Anticancer Plants Inducing Apoptosis.
Biba Veerabhadran SobhanaRead more →
Solid Lipid Nanoparticles: The Frontier in Drug Delivery.
Riyaz Ali M. Osmani, Rohi...Read more →
Review on Self Nanoemulsifying Drug Delivery System
Chetan Amrutkar, K.S. Sal...Read more →
More by These Authors
Colon specific delivery of Eudragit E-100 and Eudragit RL-100 coated tablets of Rifaximin Using chitosan-chondroitin sulphate Interpolymer complex
2013 • Vol. 3, Issue 6
Read more →Floating Bilayer drug delivery systems- An Unconventional approach in Conventional Form
2012 • Vol. 2, Issue 2
Read more →Post Approval Regulatory Requirements for A New Drug Application (NDA)
2013 • Vol. 3, Issue 1
Read more →